Growth Metrics

Surgery Partners (SGRY) Cash from Investing Activities (2016 - 2025)

Surgery Partners (SGRY) has disclosed Cash from Investing Activities for 12 consecutive years, with -$126.1 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 12.89% to -$126.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$246.6 million through Dec 2025, up 49.52% year-over-year, with the annual reading at -$246.6 million for FY2025, 49.52% up from the prior year.
  • Cash from Investing Activities hit -$126.1 million in Q4 2025 for Surgery Partners, down from -$46.2 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $2.1 million in Q2 2025 to a low of -$244.1 million in Q2 2024.
  • Historically, Cash from Investing Activities has averaged -$80.0 million across 5 years, with a median of -$71.0 million in 2023.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 444.71% in 2021 and later soared 100.86% in 2025.
  • Year by year, Cash from Investing Activities stood at -$190.0 million in 2021, then skyrocketed by 62.0% to -$72.2 million in 2022, then rose by 19.53% to -$58.1 million in 2023, then plummeted by 92.25% to -$111.7 million in 2024, then fell by 12.89% to -$126.1 million in 2025.
  • Business Quant data shows Cash from Investing Activities for SGRY at -$126.1 million in Q4 2025, -$46.2 million in Q3 2025, and $2.1 million in Q2 2025.